Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 134
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Am J Kidney Dis ; 70(3): 440-444, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28599903

RESUMO

Hypobicarbonatemia, or a reduced bicarbonate concentration in plasma, is a finding seen in 3 acid-base disorders: metabolic acidosis, chronic respiratory alkalosis and mixed metabolic acidosis and chronic respiratory alkalosis. Hypobicarbonatemia due to chronic respiratory alkalosis is often misdiagnosed as a metabolic acidosis and mistreated with the administration of alkali therapy. Proper diagnosis of the cause of hypobicarbonatemia requires integration of the laboratory values, arterial blood gas, and clinical history. The information derived from the urinary response to the prevailing acid-base disorder is useful to arrive at the correct diagnosis. We discuss the use of urine anion gap, as a surrogate marker of urine ammonium excretion, in the evaluation of a patient with low plasma bicarbonate concentration to differentiate between metabolic acidosis and chronic respiratory alkalosis. The interpretation and limitations of urine acid-base indexes at bedside (urine pH, urine bicarbonate, and urine anion gap) to evaluate urine acidification are discussed.


Assuntos
Acidose/diagnóstico , Alcalose Respiratória , Hiperventilação , Acidente Vascular Cerebral/complicações , Desequilíbrio Hidroeletrolítico , Idoso de 80 Anos ou mais , Alcalose Respiratória/sangue , Alcalose Respiratória/diagnóstico , Alcalose Respiratória/etiologia , Diagnóstico Diferencial , Gerenciamento Clínico , Feminino , Humanos , Concentração de Íons de Hidrogênio , Hiperventilação/sangue , Hiperventilação/etiologia , Desequilíbrio Hidroeletrolítico/sangue , Desequilíbrio Hidroeletrolítico/diagnóstico , Desequilíbrio Hidroeletrolítico/etiologia
3.
JAMA ; 315(5): 480-8, 2016 Feb 02.
Artigo em Inglês | MEDLINE | ID: mdl-26836730

RESUMO

IMPORTANCE: Acetazolamide has been used for decades as a respiratory stimulant for patients with chronic obstructive pulmonary disease (COPD) and metabolic alkalosis, but no large randomized placebo-controlled trial is available to confirm this approach. OBJECTIVE: To determine whether acetazolamide reduces mechanical ventilation duration in critically ill patients with COPD and metabolic alkalosis. DESIGN, SETTING, AND PARTICIPANTS: The DIABOLO study, a randomized, double-blind, multicenter trial, was conducted from October 2011 through July 2014 in 15 intensive care units (ICUs) in France. A total of 382 patients with COPD who were expected to receive mechanical ventilation for more 24 hours were randomized to the acetazolamide or placebo group and 380 were included in an intention-to treat analysis. INTERVENTIONS: Acetazolamide (500-1000 mg, twice daily) vs placebo administered intravenously in cases of pure or mixed metabolic alkalosis, initiated within 48 hours of ICU admission and continued during the ICU stay for a maximum of 28 days. MAIN OUTCOMES AND MEASURES: The primary outcome was the duration of invasive mechanical ventilation via endotracheal intubation or tracheotomy. Secondary outcomes included changes in arterial blood gas and respiratory parameters, weaning duration, adverse events, use of noninvasive ventilation after extubation, successful weaning, the duration of ICU stay, and in-ICU mortality. RESULTS: Among 382 randomized patients, 380 (mean age, 69 years; 272 men [71.6%]; 379 [99.7%] with endotracheal intubation) completed the study. For the acetazolamide group (n = 187), compared with the placebo group (n = 193), no significant between-group differences were found for median duration of mechanical ventilation (-16.0 hours; 95% CI, -36.5 to 4.0 hours; P = .17), duration of weaning off mechanical ventilation (-0.9 hours; 95% CI, -4.3 to 1.3 hours; P = .36), daily changes of minute-ventilation (-0.0 L/min; 95% CI, -0.2 to 0.2 L/min; P = .72), or partial carbon-dioxide pressure in arterial blood (-0.3 mm Hg; 95% CI, -0.8 to 0.2 mm Hg; P = .25), although daily changes of serum bicarbonate (between-group difference, -0.8 mEq/L; 95% CI, -1.2 to -0.5 mEq/L; P < .001) and number of days with metabolic alkalosis (between-group difference, -1; 95% CI, -2 to -1 days; P < .001) decreased significantly more in the acetazolamide group. Other secondary outcomes also did not differ significantly between groups. CONCLUSIONS AND RELEVANCE: Among patients with COPD receiving invasive mechanical ventilation, the use of acetazolamide, compared with placebo, did not result in a statistically significant reduction in the duration of invasive mechanical ventilation. However, the magnitude of the difference was clinically important, and it is possible that the study was underpowered to establish statistical significance. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01627639.


Assuntos
Acetazolamida/administração & dosagem , Alcalose Respiratória/terapia , Inibidores da Anidrase Carbônica/administração & dosagem , Doença Pulmonar Obstrutiva Crônica/terapia , Respiração Artificial/estatística & dados numéricos , Idoso , Alcalose Respiratória/sangue , Bicarbonatos/sangue , Dióxido de Carbono/sangue , Método Duplo-Cego , Feminino , Humanos , Análise de Intenção de Tratamento , Masculino , Doença Pulmonar Obstrutiva Crônica/sangue , Respiração Artificial/métodos , Fatores de Tempo , Resultado do Tratamento , Desmame do Respirador/estatística & dados numéricos
4.
Anesthesiology ; 115(4): 791-803, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21934407

RESUMO

BACKGROUND: Although accumulating evidence suggests that arousal pathways in the brain play important roles in emergence from general anesthesia, the roles of monoaminergic arousal circuits are unclear. In this study, the authors tested the hypothesis that methylphenidate (an inhibitor of dopamine and norepinephrine transporters) induces emergence from isoflurane general anesthesia. METHODS: Using adult rats, the authors tested the effect of intravenous methylphenidate on time to emergence from isoflurane general anesthesia. They then performed experiments to test separately for methylphenidate-induced changes in arousal and changes in minute ventilation. A dose-response study was performed to test for methylphenidate-induced restoration of righting during continuous isoflurane general anesthesia. Surface electroencephalogram recordings were performed to observe neurophysiological changes. Plethysmography recordings and arterial blood gas analysis were performed to assess methylphenidate-induced changes in respiratory function. Intravenous droperidol was administered to test for inhibition of methylphenidate's actions. RESULTS: Methylphenidate decreased median time to emergence from 280 to 91 s. The median difference in time to emergence without methylphenidate compared with administration of methylphenidate was 200 [155-331] s (median, [95% CI]). During continuous inhalation of isoflurane, methylphenidate induced return of righting in a dose-dependent manner, induced a shift in electroencephalogram power from delta (less than 4 Hz) to theta (4-8 Hz), and induced an increase in minute ventilation. Administration of intravenous droperidol (0.5 mg/kg) before intravenous methylphenidate (5 mg/kg) largely inhibited methylphenidate-induced emergence behavior, electroencephalogram changes, and changes in minute ventilation. CONCLUSIONS: Methylphenidate actively induces emergence from isoflurane general anesthesia by increasing arousal and respiratory drive, possibly through activation of dopaminergic and adrenergic arousal circuits. The authors' findings suggest that methylphenidate may be useful clinically as an agent to reverse general anesthetic-induced unconsciousness and respiratory depression at the end of surgery.


Assuntos
Período de Recuperação da Anestesia , Anestesia Geral , Estimulantes do Sistema Nervoso Central/farmacologia , Metilfenidato/farmacologia , Adjuvantes Anestésicos/farmacologia , Algoritmos , Alcalose Respiratória/sangue , Alcalose Respiratória/induzido quimicamente , Anestésicos Inalatórios , Animais , Nível de Alerta/efeitos dos fármacos , Gasometria , Pressão Sanguínea/efeitos dos fármacos , Droperidol/farmacologia , Eletroencefalografia/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Hemodinâmica/efeitos dos fármacos , Isoflurano , Masculino , Pletismografia , Equilíbrio Postural/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Mecânica Respiratória/efeitos dos fármacos
5.
BMJ Case Rep ; 14(1)2021 Jan 11.
Artigo em Inglês | MEDLINE | ID: mdl-33431479

RESUMO

Here we present the case of a 37-year-old previously healthy man who developed fever, headache and a unilateral, painful neck swelling while working offshore. He had no known contact with anyone with COVID-19; however, due to the ongoing pandemic, a nasopharyngeal swab was performed, which was positive for the virus. After transfer to hospital for assessment his condition rapidly deteriorated, requiring admission to intensive care for COVID-19 myocarditis. One week after discharge he re-presented with unilateral facial nerve palsy. Our case highlights an atypical presentation of COVID-19 and the multifaceted clinical course of this still poorly understood disease.


Assuntos
Alcalose Respiratória/sangue , Paralisia de Bell/fisiopatologia , COVID-19/fisiopatologia , Miocardite/fisiopatologia , Adulto , Alcalose Respiratória/etiologia , Gasometria , Proteína C-Reativa/metabolismo , COVID-19/sangue , COVID-19/terapia , Ecocardiografia , Edema/etiologia , Eletrocardiografia , Humanos , Hipotensão/etiologia , Hipotensão/fisiopatologia , Linfadenite/etiologia , Linfadenite/fisiopatologia , Imageamento por Ressonância Magnética , Masculino , Miocardite/sangue , Miocardite/diagnóstico por imagem , Miocardite/terapia , Peptídeo Natriurético Encefálico/sangue , Pescoço , Oxigenoterapia , Fragmentos de Peptídeos/sangue , Pró-Calcitonina/sangue , Recuperação de Função Fisiológica , SARS-CoV-2 , Troponina T/sangue , Vasoconstritores/uso terapêutico
6.
Pediatr Emerg Care ; 26(2): 134-8, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20145505

RESUMO

We present a 19-month-old boy with a history of asthma who presented to the pediatric emergency department with noisy breathing and tachypnea partially responsive to albuterol. He was discharged to routine care at home. His parents brought him back the next day for persistent respiratory distress despite routine home albuterol. A check of electrolytes showed a low bicarbonate level.


Assuntos
Aspirina/intoxicação , Asma/complicações , Hiperventilação/induzido quimicamente , Equilíbrio Ácido-Base , Albuterol/uso terapêutico , Alcalose Respiratória/sangue , Alcalose Respiratória/induzido quimicamente , Asma/tratamento farmacológico , Bicarbonatos/sangue , Mordeduras Humanas/complicações , Maus-Tratos Infantis , Cloretos/sangue , Deficiências do Desenvolvimento/complicações , Emergências , Humanos , Hiperventilação/sangue , Lactente , Masculino , Intoxicação/sangue , Intoxicação/diagnóstico , Recidiva , Salicilatos/sangue
7.
Am J Emerg Med ; 26(9): 975-80, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19091262

RESUMO

INTRODUCTION: Since the invention of the pulse oximeter, physicians often or even routinely perform venous blood gas analysis (VBGA). However, it has not been generally agreed that the application of VBGA is practically meaningful in routine clinical situations such as in an ED. METHODS: We measured venous-arterial Pco(2) difference ((v-a)Pco(2)) and arterial-venous pH difference ((a-v)pH), and analyzed the physiological factors that affect these differences in healthy volunteers and hyperventilation patients. RESULTS: In healthy volunteers, both (v-a)Pco(2) and (a-v)pH increased during finger exercise or hyperventilation in an intensity-dependent manner. Doppler echography indicated that increases in (v-a)Pco(2) and (a-v)pH during hyperventilation are induced by reduction of peripheral blood flow. Approximately 40% of patients with untreated respiratory alkalosis were found to be incorrectly diagnosed if based only on VBGA. CONCLUSIONS: It must be noted that VBGA may lead to overestimation of acidosis and to underestimation of respiratory alkalosis when extremities muscles are active or patients are hyperventilating. Physicians should keep these limitations in mind when conducting VBGA.


Assuntos
Alcalose Respiratória/diagnóstico , Gasometria/métodos , Hiperventilação/sangue , Acidose/sangue , Acidose/diagnóstico , Adolescente , Adulto , Idoso , Alcalose Respiratória/sangue , Erros de Diagnóstico , Exercício Físico/fisiologia , Feminino , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-Idade , Adulto Jovem
8.
Exp Clin Transplant ; 16(6): 754-756, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30119620

RESUMO

An interaction between regained renal function in a transplanted kidney and hyperventilation syndrome may interfere with correct diagnosis of acid-base status in patients with preoperative nongap acidosis. Here, we present a patient with glomerular nephritis and hyperchloremia who underwent kidney transplant. Progressively increasing bicarbonate reabsorption by the renal graft, which thereby changed the arterial carbon dioxide tension-to-bicarbonate ratio, resulted in a time-sequence swing of an acid-base interpretation despite persistent mixed respiratory alkalosis due to hyperventilation syndrome and nongap metabolic acidosis due to preexisting hyperchloremia. Specifically, the sequence was mixed primary metabolic acidosis and primary respiratory acidosis immediately after surgery, primary metabolic acidosis and secondary respiratory alkalosis on postoperative days 1 and 2, mixed primary hyperchloremic metabolic acidosis and primary respiratory alkalosis on postoperative day 3, and finally primary respiratory alkalosis and secondary hyperchloremic metabolic acidosis on postoperative day 7. This swing in the acid-base interpretation indicates that the acid-base imbalance described here does not fit the empirical relationship for calculating the expected bicarbonate or carbon dioxide tension value, suggesting that "correct" interpretation of acid-base status may not lead to "correct" diagnosis of acid-base status. It should be remembered that not every acid-base imbalance fits the empirical relationship.


Assuntos
Equilíbrio Ácido-Base , Acidose/fisiopatologia , Alcalose Respiratória/fisiopatologia , Cloretos/sangue , Hiperventilação/fisiopatologia , Transplante de Rim/efeitos adversos , Rim/fisiopatologia , Rim/cirurgia , Acidose/sangue , Acidose/diagnóstico , Acidose/etiologia , Adulto , Alcalose Respiratória/sangue , Alcalose Respiratória/diagnóstico , Alcalose Respiratória/etiologia , Bicarbonatos/sangue , Biomarcadores/sangue , Humanos , Hiperventilação/sangue , Hiperventilação/diagnóstico , Hiperventilação/etiologia , Masculino , Valor Preditivo dos Testes , Recuperação de Função Fisiológica , Reprodutibilidade dos Testes , Síndrome , Fatores de Tempo , Resultado do Tratamento
9.
Respir Physiol Neurobiol ; 156(2): 220-8, 2007 May 14.
Artigo em Inglês | MEDLINE | ID: mdl-17049933

RESUMO

In order to address the possible role of blood acid-base status in controlling the rectal gland, dogfish were fitted with indwelling arterial catheters for blood sampling and rectal gland catheters for secretion collection. In intact, unanaesthetized animals, isosmotic volume loading with 500 mmol L-1 NaCl at a rate of 15 mL kg-1 h-1 produced a brisk, stable rectal gland secretion flow of about 4 mL kg-1 h-1. Secretion composition (500 mmol L-1 Na+ and Cl-; 5 mmol L-1 K+; <1 mmol L-1 Ca2+, Mg2+, SO(4)2-, or phosphate) was almost identical to that of the infusate with a pH of about 7.2, HCO3- mmol L-1<1 mmol L-1 and a PCO2 (1 Torr) close to PaCO2. Experimental treatments superimposed on the infusion caused the expected disturbances in systemic acid-base status: respiratory acidosis by exposure to high environmental PCO2, metabolic acidosis by infusion of HCl, and metabolic alkalosis by infusion of NaHCO3. Secretion flow decreased markedly with acidosis and increased with alkalosis, in a linear relationship with extracellular pH. Secretion composition did not change, apart from alterations in its acid-base status, and made negligible contribution to overall acid-base balance. An adaptive control of rectal gland secretion by systemic acid-base status is postulated-stimulation by the "alkaline tide" accompanying the volume load of feeding and inhibition by the metabolic acidosis accompanying the volume contraction of exercise.


Assuntos
Equilíbrio Ácido-Base/fisiologia , Acidose Respiratória/sangue , Cação (Peixe)/fisiologia , Glândula de Sal/fisiologia , Equilíbrio Hidroeletrolítico/fisiologia , Alcalose Respiratória/sangue , Animais , Glândula de Sal/metabolismo
10.
Nurs Times ; 103(8): 42-3, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17333876

RESUMO

In the third and final part of this series looking at blood gas analysis, Liz Allibone and Nicola Nation provide three examples of how arterial blood gas results assist in the diagnosis and management of illness.


Assuntos
Gasometria , Acidose Respiratória/sangue , Acidose Respiratória/diagnóstico , Adolescente , Alcalose Respiratória/sangue , Alcalose Respiratória/diagnóstico , Feminino , Humanos , Masculino
11.
Ugeskr Laeger ; 179(18)2017 May 01.
Artigo em Dinamarquês | MEDLINE | ID: mdl-28473024

RESUMO

Long-distance athletes are at risk of serious fluid and electrolyte disturbances, such as hypernatraemia (dehydration). Recently, cases of serious morbidity have been reported, due to acute exercise-associated hyponatraemia, which can advance to encephalopathy. An arterial blood gas analysis (ABG) was drawn from collapsed athletes at the championship of full-distance triathlon 2015, and different electrolyte imbalances were found. Our findings show that prehospital ABG can assist in differentiating the cause of collapse, and presumably, targeted treatment can be initiated already on scene.


Assuntos
Ciclismo/fisiologia , Gasometria , Corrida/fisiologia , Natação/fisiologia , Desequilíbrio Hidroeletrolítico , Adulto , Alcalose Respiratória/sangue , Serviços Médicos de Emergência , Humanos , Masculino , Cloreto de Sódio/administração & dosagem , Desequilíbrio Hidroeletrolítico/sangue , Desequilíbrio Hidroeletrolítico/etiologia , Desequilíbrio Hidroeletrolítico/terapia
12.
Nefrologia ; 36(4): 347-53, 2016.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-27267918

RESUMO

Hyperchloremia is a common electrolyte disorder that is associated with a diverse group of clinical conditions. The kidney plays an important role in the regulation of chloride concentration through a variety of transporters that are present along the nephron. Nevertheless, hyperchloremia can occur when water losses exceed sodium and chloride losses, when the capacity to handle excessive chloride is overwhelmed, or when the serum bicarbonate is low with a concomitant rise in chloride as occurs with a normal anion gap metabolic acidosis or respiratory alkalosis. The varied nature of the underlying causes of the hyperchloremia will, to a large extent, determine how to treat this electrolyte disturbance.


Assuntos
Cloretos/sangue , Néfrons/metabolismo , Desequilíbrio Hidroeletrolítico/etiologia , Equilíbrio Ácido-Base , Acidose/sangue , Alcalose Respiratória/sangue , Bicarbonatos/sangue , Permeabilidade da Membrana Celular , Formiatos/metabolismo , Humanos , Transporte de Íons , Túbulos Renais Proximais/metabolismo , Proteínas de Membrana Transportadoras/metabolismo , Natriurese , Oxalatos/metabolismo , Desequilíbrio Hidroeletrolítico/metabolismo
13.
Int J Sports Physiol Perform ; 11(7): 627-34, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26562929

RESUMO

UNLABELLED: Relatively long-lasting metabolic alkalizing procedures such as bicarbonate ingestion have potential for improving performance in long-sprint to middle-distance events. Within a few minutes, hyperventilation can induce respiratory alkalosis. However, corresponding performance effects are missing or equivocal at best. PURPOSE: To test a potential performance-enhancing effect of respiratory alkalosis in a 30-s Wingate Anaerobic Test (WAnT). METHODS: 10 men (mean ± SD age 26.6 ± 4.9 y, height 184.4 ± 6.1 cm, body-mass test 1 80.7 ± 7.7 kg, body-mass test 2 80.4 ± 7.2 kg, peak oxygen uptake 3.95 ± 0.43 L/min) performed 2 WAnTs, 1 with and 1 without a standardized 15-min hyperventilation program pre-WAnT in randomized order separated by 1 wk. RESULTS: Compared with the control condition, hyperventilation reduced (all P < .01) pCO2 (40.5 ± 2.8 vs 22.5 ± 1.6 mm Hg) and HCO3 - (25.5 ± 1.7 vs 22.7 ± 1.6 mmol/L) and increased (all P < .01) pH (7.41 ± 0.01 vs 7.61 ± 0.03) and actual base excess (1.4 ± 1.4 vs 3.2 ± 1.6 mmol/L) pre-WAnT with an ergogenic effect on WAnT average power (681 ± 41 vs 714 ± 44 W) and total metabolic energy (138 ± 12 vs. 144 ± 13 kJ) based on an increase in glycolytic energy (81 ± 13 vs 88 ± 13 kJ). CONCLUSION: Hyperventilation-induced respiratory alkalosis can enhance WAnT cycling sprint performance well in the magnitude of what is seen after successful bicarbonate ingestion.


Assuntos
Equilíbrio Ácido-Base , Alcalose Respiratória/fisiopatologia , Limiar Anaeróbio , Teste de Esforço/métodos , Hiperventilação/fisiopatologia , Pulmão/fisiopatologia , Músculo Esquelético/fisiopatologia , Corrida , Adulto , Alcalose Respiratória/sangue , Bicarbonatos/sangue , Biomarcadores/sangue , Dióxido de Carbono/sangue , Metabolismo Energético , Glicólise , Humanos , Concentração de Íons de Hidrogênio , Hiperventilação/sangue , Ácido Láctico/sangue , Masculino , Força Muscular , Músculo Esquelético/metabolismo , Valor Preditivo dos Testes , Fatores de Tempo , Adulto Jovem
14.
Arch Intern Med ; 145(4): 746-7, 1985 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3985739

RESUMO

A 61-year-old man with end-stage renal disease developed severe hyperventilation following nortriptyline hydrochloride usage for depression. He required mechanical ventilation and paralysis to correct severe respiratory alkalosis. To our knowledge, nortriptyline usage has not been previously associated with hyperventilation.


Assuntos
Alcalose Respiratória/induzido quimicamente , Nortriptilina/efeitos adversos , Alcalose Respiratória/sangue , Gasometria , Humanos , Masculino , Pessoa de Meia-Idade , Nortriptilina/sangue
15.
Eur J Gastroenterol Hepatol ; 27(8): 920-7, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26011230

RESUMO

PURPOSE: Acid-base disturbances were investigated in patients with cirrhosis in relation to hemodynamic derangement to analyze the hyperventilatory effects and the metabolic compensation. METHODS: A total of 66 patients with cirrhosis and 44 controls were investigated during a hemodynamic study. RESULTS: Hyperventilatory hypocapnia was present in all patients with cirrhosis and progressed from Child class A to C (P<0.01). Arterial pH increased significantly from class A to C (P<0.001) and was correlated inversely to the mean arterial blood pressure (r=-0.30, P<0.02), systemic vascular resistance (r=-0.25, P<0.05), indocyanine green clearance (r=-0.37, P<0.005), and serum sodium (r=-0.38, P<0.002). Metabolic compensation was shown by a reduced standard base excess in all patients (P<0.001). Standard base excess contained elements related to changes in serum albumin, water dilution, and effects of unidentified ions (all P<0.001). A significant hepatic component in the acid-base disturbances could not be identified. CONCLUSION: Hypocapnic alkalosis is related to disease severity and hyperdynamic systemic circulation in patients with cirrhosis. The metabolic compensation includes alterations in serum albumin and water retention that may result in a delicate acid-base balance in these patients.


Assuntos
Equilíbrio Ácido-Base , Alcalose Respiratória/etiologia , Hemodinâmica , Cirrose Hepática/complicações , Adulto , Idoso , Alcalose Respiratória/sangue , Alcalose Respiratória/diagnóstico , Alcalose Respiratória/mortalidade , Alcalose Respiratória/fisiopatologia , Biomarcadores/sangue , Estudos de Casos e Controles , Feminino , Humanos , Concentração de Íons de Hidrogênio , Hiperventilação/etiologia , Hiperventilação/fisiopatologia , Hipocapnia/etiologia , Hipocapnia/fisiopatologia , Estimativa de Kaplan-Meier , Circulação Hepática , Cirrose Hepática/sangue , Cirrose Hepática/diagnóstico , Cirrose Hepática/mortalidade , Cirrose Hepática/fisiopatologia , Masculino , Pessoa de Meia-Idade , Modelos Biológicos , Prognóstico , Fatores de Risco , Albumina Sérica/análise , Albumina Sérica Humana , Índice de Gravidade de Doença , Sódio/sangue , Fatores de Tempo
16.
J Bone Miner Res ; 18(8): 1478-85, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12929937

RESUMO

UNLABELLED: Acute alkalosis may directly affect PTH secretion. The effect of acute metabolic and respiratory alkalosis was studied in 20 dogs. PTH values were lower in the metabolic (5.6 +/- 0.8 pg/ml) and respiratory (1.8 +/- 0.6 pg/ml) alkalosis groups than in the control group (27 +/- 5 pg/ml). Acute alkalosis is an independent factor that decreases PTH values during normocalcemia and delays the PTH response to hypocalcemia. INTRODUCTION: We recently showed that acute metabolic and respiratory acidosis stimulated PTH secretion. This study was designed to evaluate whether acute metabolic and respiratory alkalosis suppressed parathyroid hormone (PTH) secretion. MATERIALS AND METHODS: Three groups of 10 dogs were studied: control, acute metabolic alkalosis, and acute respiratory alkalosis. Metabolic alkalosis was induced with an infusion of sodium bicarbonate and respiratory alkalosis by hyperventilation. Calcium chloride was infused to prevent alkalosis-induced hypocalcemia during the first 60 minutes. During the next 30 minutes, disodium EDTA was infused to induce hypocalcemia and to evaluate the PTH response to hypocalcemia. Because the infusion of sodium bicarbonate resulted in hypernatremia, the effect of hypernatremia was studied in an additional group that received hypertonic saline. RESULTS: After 60 minutes of a normocalcemic clamp, PTH values were less (p < 0.05) in the metabolic (5.6 +/- 0.8 pg/ml) and respiratory (1.8 +/- 0.6 pg/ml) alkalosis groups than in the control group (27 +/- 5 pg/ml); the respective blood pH values were 7.61 +/- 0.01, 7.59 +/- 0.02, and 7.39 +/- 0.02. The maximal PTH response to hypocalcemia was similar among the three groups. However, the maximal PTH response was observed after a decrease in ionized calcium of 0.20 mM in the control group but not until a decrease of 0.40 mM in the metabolic and respiratory alkalosis groups. In contrast to the metabolic alkalosis group, hypernatremia (157 +/- 2 mEq/liter) in the hypertonic saline group was associated with an increased PTH value (46 +/- 4 pg/ml). Finally, the half-life of intact PTH was not different among the control and two alkalosis groups. CONCLUSIONS: Acute metabolic and respiratory alkalosis markedly decreased PTH values during normocalcemia and delayed the PTH response to hypocalcemia. Whether acute metabolic and respiratory alkalosis affect PTH and calcium metabolism in such settings as the postprandial alkaline tide (metabolic alkalosis) and acute sepsis (respiratory alkalosis) deserves to be evaluated in future studies.


Assuntos
Alcalose Respiratória/fisiopatologia , Hormônio Paratireóideo/metabolismo , Doença Aguda , Alcalose Respiratória/sangue , Animais , Cálcio/sangue , Cálcio/farmacologia , Cães , Meia-Vida , Concentração de Íons de Hidrogênio , Hormônio Paratireóideo/sangue , Fosfatos/sangue , Sódio/sangue , Fatores de Tempo
17.
Medicine (Baltimore) ; 56(1): 38-54, 1977 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-401925

RESUMO

The concepts underlying the clinical use of the anion gap (AG) and those disorders associated with its alteration are reviewed. A substantial increase in the AG usually indicates the presence of a metabolic acidosis, unless large doses of certain antibiotics or sodium salts of organic acids are being used. The etiology, pathogenesis and diagnosis of high AG metabolic acidoses are discussed. Stress is placed upon the utility of the AG in defining the cause of the acidosis, and as a guide to therapy in certain organic acidoses. A decrease in the normal AG occurs in dilutional states, hypoalbuminemia, hypercalcemia, hypermagnesemia, hypernatremia, diseases associated with hyperviscosity, bromide intoxication, and in certain paraproteinemias. The important clue provided by a low or negative AG in the diagnosis of certain of these life-threatening disorders is emphasized.


Assuntos
Desequilíbrio Ácido-Base/sangue , Acidose/sangue , Acidose/induzido quimicamente , Acidose Tubular Renal/sangue , Alcalose/sangue , Alcalose Respiratória/sangue , Aspirina/efeitos adversos , Bicarbonatos/sangue , Carbenicilina/efeitos adversos , Cetoacidose Diabética/sangue , Eletrólitos/sangue , Etilenoglicóis/intoxicação , Humanos , Cetose/sangue , Lactatos/sangue , Metanol/intoxicação , Mieloma Múltiplo/sangue , Paraldeído/intoxicação , Sódio/administração & dosagem
18.
Chest ; 98(3): 651-5, 1990 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2118447

RESUMO

The clinical features, arterial blood gases, and acid-base profile were examined in 229 consecutive episodes of acute asthma in 170 patients who required hospitalization. A simple respiratory alkalosis was the most common acid-base disturbance, occurring in 48 percent of the episodes. Metabolic acidosis, either alone or as part of a mixed disturbance, was noted in 28 percent. Of 60 episodes presenting with respiratory acidosis, 37 (62 percent) had a coexistent metabolic acidosis. Metabolic acidosis was more likely to occur in male subjects and in patients with evidence of more severe airflow obstruction. Patients with metabolic acidosis had an average anion gap of 15.8 mEq/L; these patients were more hypoxemic than those without metabolic acidosis and there was a significant inverse correlation between the anion gap and the degree of hypoxemia. We conclude that metabolic acidosis is a common finding in acute, severe asthma and suggest that the pathogenesis of lactic acidosis is multifactorial and includes contributions from lactate production by respiratory muscles, tissue hypoxia, and intracellular alkalosis.


Assuntos
Desequilíbrio Ácido-Base/etiologia , Asma/complicações , Equilíbrio Ácido-Base , Desequilíbrio Ácido-Base/sangue , Acidose/sangue , Acidose/etiologia , Acidose Respiratória/sangue , Acidose Respiratória/etiologia , Adulto , Alcalose Respiratória/sangue , Alcalose Respiratória/etiologia , Asma/sangue , Asma/fisiopatologia , Dióxido de Carbono/sangue , Volume Expiratório Forçado , Humanos , Oxigênio/sangue
19.
Chest ; 87(5): 619-24, 1985 May.
Artigo em Inglês | MEDLINE | ID: mdl-3987374

RESUMO

The effects of metabolic acidosis upon the pattern of apnea during sleep were assessed in ten sleep apnea patients. Four had pure obstructive apnea, two pure central apnea, and four had mixed apnea. Acidosis was induced with acetazolamide. Acid-base shifts had little effect in pure obstructive and pure central apnea, but had a significant effect in mixed apnea. In two of the mixed apneic patients, metabolic acidosis converted predominantly central apnea into nearly pure obstructive apnea, prolonging apneic periods and worsening hypoxemia. A suggested explanation for this is the greater stimulating effect of acidosis upon the lower bellows muscles than upon the muscles which act to maintain patency of the upper airways. The observation that some patients with mixed sleep apnea appear to have central apnea while relatively alkalotic and obstructive apnea while acidotic emphasizes the need for more careful and detailed characterization of apneic disorders with respect to their responses to body states and therapeutic agents.


Assuntos
Acidose Respiratória/fisiopatologia , Síndromes da Apneia do Sono/fisiopatologia , Sono/fisiologia , Acetazolamida/administração & dosagem , Acidose Respiratória/sangue , Acidose Respiratória/induzido quimicamente , Administração Oral , Adulto , Idoso , Alcalose Respiratória/sangue , Alcalose Respiratória/induzido quimicamente , Alcalose Respiratória/fisiopatologia , Feminino , Furosemida/administração & dosagem , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-Idade , Oxigênio/sangue , Respiração , Síndromes da Apneia do Sono/sangue
20.
Intensive Care Med ; 18(2): 89-92, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1613204

RESUMO

The effects of hypocapnic alkalosis on the vasodilating action of nicardipine were studied in 6 patients after cerebral arterial aneurysm surgery. Each patient served as his/her own control during the 6 steps of the study. T0: baseline; T1: hypocapnic alkalosis alone (PaCO2: 3.5 kPa); T2: hypocapnic alkalosis and bolus injection of nicardipine (30 micrograms.kg-1 i.v.); T3: hypocapnic alkalosis and continuous 60 min infusion of nicardipine (0.5 microgram.kg-1.min-1), T4: determination of the infusion rate required to neutralize the effect of hypocapnic alkalosis; T5: same continuous dose of nicardipine as in T4 but reversal of hypocapnic alkalosis. Hypocapnic alkalosis alone caused a significant increase in the systemic vascular resistance index by 20% (T1). The bolus injection of nicardipine reversed this first effect (T2). The continuous infusion of nicardipine in T3 was insufficient to cancel the haemodynamic effect of hypocapnic alkalosis. During T4 the plasma levels required to neutralize completely the effect of hypocapnic alkalosis were twice those at T3. Normalization of the PaCO2 in step T5 induced a significant fall in the systemic vascular resistance index by 27.5% as compared with T0. In this study hypocapnic alkalosis modified the relationship between plasma levels of nicardipine and its expected vasoactive effects. This interaction was reversible.


Assuntos
Alcalose Respiratória/complicações , Hemodinâmica/efeitos dos fármacos , Aneurisma Intracraniano/cirurgia , Ataque Isquêmico Transitório/tratamento farmacológico , Nicardipino/farmacologia , Complicações Pós-Operatórias/tratamento farmacológico , Vasodilatação/efeitos dos fármacos , Idoso , Alcalose Respiratória/sangue , Alcalose Respiratória/fisiopatologia , Gasometria , Relação Dose-Resposta a Droga , Estudos de Avaliação como Assunto , Feminino , Humanos , Ataque Isquêmico Transitório/complicações , Ataque Isquêmico Transitório/prevenção & controle , Masculino , Pessoa de Meia-Idade , Nicardipino/administração & dosagem , Nicardipino/uso terapêutico , Complicações Pós-Operatórias/prevenção & controle , Respiração Artificial/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA